Literature DB >> 18179761

Anti-TNF-alpha treatment and bile duct drainage restore cellular immunity and prevent tissue injury in experimental obstructive jaundice.

F J Padillo1, A Cruz, I Segura-Jiménez, J Ruiz-Rabelo, M R Vázquez-Ezquerra, M D Perea-Alvarez, J Peña, J Briceño, J Muntané.   

Abstract

Several experimental studies of obstructive jaundice (OJ) have shown the presence of immunosuppressive state associated with the rise of tumor necrosis factor-alpha (TNF-alpha) concentration in plasma. The present study evaluates the impact of anti-TNF- alpha administration or bile duct drainage on the inflammatory response, liver injury and renal insufficiency in obstructed rats. OJ was induced by the ligation of bile duct in Wistar rats. The parameters were determined at 14 and 21 days after OJ. Two additional groups of animals were treated with anti-TNF-alpha antibodies or submitted to bile duct drainage at 14 days, and sacrificed 21 days after OJ. Cholestasis decreased glucose, and enhanced urea, creatinin, bilirubin and transaminases. Cholestasis increased the number of different inflammatory cells (T and B lymphocytes, and monocytes-macrophages) but reduced the expression of the corresponding cellular activation markers. This low responsiveness of the inflammatory cells was related to a decreased free radical production and phagocytic activity of cells. Anti-TNF-alpha and bile duct drainage reduced tissue injury, and prevented the reduction of the number and activity of T lymphocytes and phagocytic cells observed at the advanced stages of cholestasis. In conclusion, anti-TNF- alpha and bile duct drainage improved cell immunodeficiency, and reduced liver injury, cholestasis and renal insufficiency in experimental OJ.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18179761     DOI: 10.1177/039463200702000425

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  7 in total

1.  Effect of salvia miltiorrhizae on the expressions of TLR4 protein in the liver of rats with SAP or OJ.

Authors:  Xiping Zhang; Daren Liu; Dijiong Wu; Chongmei Zhu; Jing Ye; Keyi Wang; Liang Peng; Guangchao Zhuo
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

2.  Effect of salvia miltiorrhizae on pulmonary apoptosis of rats with severe acute pancreatitis or obstructive jaundice.

Authors:  Zhang Xiping; Fu Jun; Wu Chengjun; Ma Meili; Yan Ping; Ye Jing; Yang Qijun; Zhu Feibo; Ying Rongcao
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

3.  Protective effect of Radix Astragali injection on immune organs of rats with obstructive jaundice and its mechanism.

Authors:  Rui-Ping Zhang; Xi-Ping Zhang; Yue-Fang Ruan; Shu-Yun Ye; Hong-Chan Zhao; Qi-Hui Cheng; Di-Jiong Wu
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

4.  Kidney and lung tissue modifications after BDL-induced liver injury in mice are associated with increased expression of IGFBPrP1 and activation of the NF-κB inflammation pathway.

Authors:  Zhi-Hui Hu; Yang-Yang Kong; Jun-Jie Ren; Ting-Juan Huang; Yan-Qin Wang; Li-Xin Liu
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

Review 5.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Authors:  Csaba Matyas; György Haskó; Lucas Liaudet; Eszter Trojnar; Pal Pacher
Journal:  Nat Rev Cardiol       Date:  2020-09-30       Impact factor: 32.419

6.  A simple rat model of in situ reversible obstructive jaundice in situ reversible obstructive jaundice model.

Authors:  Xin Huang; Chong-Hui Li; Ai-Qun Zhang; Zhe Kong; Wan-Qing Gu; Jia-Hong Dong
Journal:  Ann Surg Treat Res       Date:  2017-05-29       Impact factor: 1.859

7.  Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats.

Authors:  Szu-Yu Liu; Chia-Chang Huang; Shiang-Fen Huang; Tsai-Ling Liao; Nai-Rong Kuo; Ying-Ying Yang; Tzu-Hao Li; Chih-Wei Liu; Ming-Chih Hou; Han-Chieh Lin
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.